← back to search

Thomas Battaglia

New York University · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Biology, Microbiome, Antibiotics, Medicine, Antibiotic resistance, and Gut microbiome.
h-index
citations
1,008
works
11
NIH funding
primary concept
email

Recent publications

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
ESMO Open 2022cited by 34position: middledoi
Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice
Cell Host & Microbe 2021cited by 56position: middledoi
Author response: Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease
2021cited by 0position: middledoi
A single early-in-life antibiotic course increases susceptibility to DSS-induced colitis
Genome Medicine 2020cited by 51position: middledoi
Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course
Scientific Reports 2019cited by 104position: middledoi
Longitudinal Comparison of Bacterial Diversity and Antibiotic Resistance Genes in New York City Sewage
mSystems 2019cited by 32position: middledoi
Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
eLife 2018cited by 107position: middledoi
Gut Microbiome and Antibiotics
Archives of Medical Research 2017cited by 190position: middledoi
A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity
Nature Communications 2017cited by 140position: middledoi
Oxalobacter formigenes-associated host features and microbial community structures examined using the American Gut Project
Microbiome 2017cited by 83position: middledoi
Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet
Genome Medicine 2016cited by 211position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin J. Blaser · Rutgers, The State University of New Jersey7 papers (2016–2021)Victoria Ruiz · New York University3 papers (2017–2020)Zachary Kurtz · New York University3 papers (2016–2017)Huilin Li · Huadong Hospital3 papers (2016–2021)Menghan Liu · Fred Hutch Cancer Center3 papers (2017–2021)Tadasu Iizumi · New York University3 papers (2017–2019)Ken Cadwell · Translational Therapeutics (United States)2 papers (2017–2020)Richard Bonneau · Gene Therapy Laboratory2 papers (2016–2017)Lama Nazzal · New York University2 papers (2017–2021)Christian L. Müller · New York University2 papers (2016–2017)Susan Joseph · Thomas Jefferson University1 papers (2019–2019)Paul Roepman · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2022–2022)Jane M. Carlton · New York University1 papers (2019–2019)Chad M. Trent · University of North Carolina at Chapel Hill1 papers (2016–2016)Douglas Mahana · New York University1 papers (2016–2016) · 1 papers (2022–2022)Ferry Lalezari · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital1 papers (2022–2022)Kim Monkhorst · Dutch Cancer Society1 papers (2022–2022)Joseph C. Devlin · Regeneron (United States)1 papers (2021–2021)Claire Roubaud‐Baudron · New York University1 papers (2020–2020)